Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000067

President, Research & Develop. sold 15,891 shares at an average $20.18 ($320,620)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan President, Research & Develop. 2024-11-29 Sale 10b5-1 −100 $20.00 $2,000 160,788 D
Sethuraman Natarajan President, Research & Develop. 2024-12-02 Sale 10b5-1 −4,088 $20.26 $82,834 156,700 D
Sethuraman Natarajan President, Research & Develop. 2024-12-03 Sale 10b5-1 −11,703 $20.15 $235,786 144,997 D
Open-market sales · 15,891 sh · avg $20.18 · $320,620
Loading xslF345X05/wk-form4_1733264681.xml…